Genomics to Healthcare
This event will discuss how the potential of genomics could be translated to benefit health and welfare. The genomic dissection of common but complex traits has gone through a paradigm of change in unravelling the personalised basis of public health. At the same time, more and more people have their individual genomic data available either through public or private providers. The practitioners of contemporary medicine should not wait to evaluate the potential of this data source for precision public health. Pharmacogenetics helps in selecting the right drug with the best impact, and less potential for side effects, single clinical variants stratify common diseases in subgroups, and genome-wide polygenic risk scores help in providing information of personal genomic predisposition for diseases. All this advances individual prevention, diagnosis and treatment.
Organiser: National Institute for Health and Welfare